Mortality in ankylosing spondylitis according to treatment: comment on the article by Ben Shabat et al.

Li, Zhixiu; Khan, Mohammad K; Villiger, Peter M; van der Linden, Sjef; Brown, Matthew A; Khan, Muhammad A

Li, Zhixiu; Khan, Mohammad K; Villiger, Peter M; van der Linden, Sjef; Brown, Matthew A; Khan, Muhammad A.

Afiliação

Li Z; Queensland University of Technology and Princess Alexandra Hospital, Brisbane, Queensland, Australia.
Khan MK; Kent State University, Kent, Ohio.
Villiger PM; Medizinisches Zentrum Monbijou, Bern, Switzerland.
van der Linden S; University of Maastricht, Maastricht, The Netherlands.
Brown MA; King's College London, Genomics England, London, UK.
Khan MA; Case Western Reserve University, Cleveland, Ohio.

Arthritis Care Res (Hoboken) ; 74(12): 2120-2121, 2022 12.

Article em En | MEDLINE | ID: mdl-34437771

Assuntos

Espondilite Anquilosante; Humanos; Espondilite Anquilosante/diagnóstico; Espondilite Anquilosante/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espondilite Anquilosante Limite: Humans Idioma: En Revista: Arthritis Care Res (Hoboken) Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google